This study will compare the role of two drugs namely levetiracetam and sodium valproate in managing childhood epilepsy

Comparison between oral levetiracetam vs oral sodium valproate as a first line therapy in children with newly diagnosed epilepsy - a randomised controlled trial - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/071841

Enrollment

Registered

2024-08-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes

Interventions

Intervention1: Levetiracetam drug: We will give loading of levetiracetam at a dose of 40ml/kg to one group of children presenting with epilepsy to our emergency department in pgims rohtak and will be

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children aged 2-14 years with New diagnosed epilepsy

Exclusion criteria

Exclusion criteria: 1.Age less than 2 and more than 14 years 2.Simple febrile seizure 3.Seizure secondary to other condition

Design outcomes

Primary

Measure	Time frame
To compare the frequency of repeat seizure at 3 months post treatment in valproate and levetiracetam groupTimepoint: 12 weeks	—

Secondary

Measure	Time frame
To see the adverse effects of both these drugs -levetiracetam & sodium valproateTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDeepak Pahal

Pandit bhagwat Dayal Sharma postgraduate institute of medical sciences Rohtak

ndvaswani@hotmail.com9034428284

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026